New York, New York, United States
The teams and clients I have worked with describe the same experience: an award-winning strategist and team player who arrives with a clear point of view, builds go-to-market frameworks that actually scale, and leaves brands in a stronger market position than when we started. Over 15 years, I have led brand strategy, omnichannel campaigns, and integrated strategy-through-deployment for F-500 companies across pharma, healthcare, telecom, technology, and CPG. My work consistently spans General Market and Multicultural segments, whether the audience is a patient navigating a diagnosis, a consumer choosing between competing products, or a business evaluating a technology platform, with a sharp focus on brand scaling, segment expansion, and full-funnel execution that converts insight into measurable growth. At GSK, vaccine brand launches and relaunches exceeded business objectives by double digits, earning recognition from senior leadership and clients. At Gilead and Novo Nordisk, cross-functional teams credited my patient segmentation, messaging strategy, and multicultural GTM expansion as critical to record-breaking patient reach and sustained brand growth. Across Spectrum, MSN, Unilever, and Nestlé, peers recognized the same discipline applied to consumer and technology categories where audience precision determines market outcomes. Colleagues consistently point to my integration of AI-driven consumer insight with disciplined brand strategy and omnichannel execution, including budget oversight and ROI analytics, delivered effectively in both compliance-driven and fast-moving consumer environments. Recognition: 2026 DTC Perspectives Gold · 2026 PM360 Pharma Choice · WPP High-Flyers · CTAM Gold · NAMIC Gold · AHA Teamwork Excellence Companies I've had the privilege of building brands with: Gilead, Novo Nordisk, GSK, Amgen, Merck, American Heart Association, Unilever, Nestlé, MSN, HP, Colgate-Palmolive, Spectrum, and Altice/Optimum. If your brand needs to scale, capture new market share, or sharpen its go-to-market strategy, the people I have worked with would tell you: start the conversation.